Series B - SAB Biotherapeutics - Jul 17, 2020 Funding Round Profile - Cointime

Bitcoin $95,697.48 -1.63%
Ethereum $3,326.07 -0.94%
BNB $657.69 -0.60%
Optimism $1.79 +0.89%
Arbitrum $0.76 +0.85%
Solana $182.56 -0.21%
Polygon $0.48 +1.21%
Cosmos $6.56 -0.24%
Avalanche $37.54 -1.01%

Bitcoin $95,697.48 -1.63%
Ethereum $3,326.07 -0.94%
BNB $657.69 -0.60%
Optimism $1.79 +0.89%
Arbitrum $0.76 +0.85%
Solana $182.56 -0.21%
Polygon $0.48 +1.21%
Cosmos $6.56 -0.24%
Avalanche $37.54 -1.01%

SAB Biotherapeutics

company

Funding Round

Series B

Money Raised

$ 14M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 7, 2016	Grant	$ 1.42M	National Institutes of Health	Detail